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The Runx3 transcription factor regulates development of T cells during thymopoiesis and TrkC sensory neurons during dorsal root ganglia
neurogenesis. It also mediates transforming growth factor-β signaling in dendritic cells and is essential for development of skin Langerhans cells.
Here, we report that Runx3 is involved in the development of skin dendritic epidermal T cells (DETCs); an important component of tissue
immunoregulation. In developing DETCs, Runx3 regulates expression of the αEβ7 integrin CD103, known to affect migration and epithelial
retention of DETCs. It also regulates expression of IL-2 receptor β (IL-2Rβ) that mediates cell proliferation in response to IL-2 or IL-15. In the
absence of Runx3, the reduction in CD103 and IL-2Rβ expression on Runx3−/− DETC precursors resulted in impaired cell proliferation and
maturation, leading to complete lack of skin DETCs in Runx3−/− mice. The data demonstrate the requirement of Runx3 for DETCs development
and underscore the importance of CD103 and IL-2Rβ in this process. Of note, while Runx3−/− mice lack both DETCs and Langerhans cells, the
two most important components of skin immune surveillance, the mice did not develop skin lesions under pathogen-free (SPF) conditions.
© 2006 Elsevier Inc. All rights reserved.Keywords: Runx3-deficient mice; Transcription regulation; Skin DETCs; Vg3 T cell development; CD103 integrin; IL-2RβIntroduction
Developing T lymphocytes are divided into subclasses
according to surface expression of T cell receptors (TCR) αβ or
γδ (Pennington et al., 2005). Most γδ T cells reside in the
epithelial layers of tissues such as skin and intestinal epithelium
(Hayday et al., 2001). In mice, skin associated intraepithelial
γδ T cells have a marked dendritic morphology and are known
as DETCs. These intraepithelial γδ T cells are thought to
recognize stress-induced and pathogen-derived antigens and to
play an important role in the first line of epithelial immune
defense (Kabelitz et al., 2005). The unique specificity of
DETCs is conferred by an invariant skin-specific TCR
composed of Vγ3/Vδ1 TCR chains lacking junctional diversity
(Hayday and Tigelaar, 2003).
Vγ3 cells, the precursors to skin resident DETCs (Payer et
al., 1991), appear in thymus at embryonal days (E) 14–16
(Havran and Allison, 1988; Ito et al., 1989; Lafaille et al., 1989).⁎ Corresponding author. Fax: +972 8 9344108.
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doi:10.1016/j.ydbio.2006.12.005Immature Vγ3 thymocytes with high heat-stable antigen
(HSAhigh) develop into mature HSAmed/low cells (Leclercq et
al., 1993), which subsequently migrate to the skin. From E16
on, the relative number of Vγ3 cells in the thymus decreases
and becomes nearly undetectable at late stages of fetal
development (Havran and Allison, 1990). Skin DETCs appear
in fetal epidermis at E17–E19 (Havran and Allison, 1988) and
maintain their round shape until birth; their typical dendritic
morphology is acquired only postnatally as the density of DETC
clusters in the skin increases into adulthood (Payer et al., 1991).
Cultured mature Vγ3 thymocytes require IL-2 for proliferation,
but IL-2-deficient mice have normal numbers of Vγ3 cells
(Leclercq et al., 1990b). This occurrence was attributed to in
vivo activity of IL-15 which can also support the proliferation of
mature Vγ3 thymocytes (Leclercq et al., 1996). IL-2 and IL-15
are both ligands of the IL-2 receptor β (IL-2Rβ), expressed on
mature Vγ3 thymocytes (Leclercq et al., 1995). In IL-15 and IL-
2Rβ-deficient mice, the number of mature Vγ3 thymocytes is
reduced and adult skin Vγ3 DETCs are absent (De Creus et al.,
2002; Kawai et al., 1998). Thus, signaling through IL-2Rβ
plays a critical role in Vγ3 T cell proliferation and survival.
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lial lymphocytes (Kilshaw and Baker, 1988) and confers
specificity for the epithelial ligand E-cadherin (Cepek et al.,
1994). The interaction of CD103 with E-cadherin is assumed to
mediate the epithelial retention of mucosal T lymphocytes and
could explain the low number of mucosal T cells in CD103-
deficient mice (Schon et al., 1999). CD103 is also expressed on
most Vγ3 DETCs and may affect their immigration and retention
in epidermis, consistent with the marked reduction of DETCs in
CD103-deficient mice (Schon et al., 2002). Interestingly, both
CD103-deficient andTCRδ-deficientmice spontaneously develop
inflammatory skin lesions (Girardi et al., 2002; Schon et al., 2000).
The αEβ7 integrin CD103 is a heterodimer composed of two
chains (αE and β7) each encoded by a separate gene (Robinson et
al., 2001). In vitro studies indicated that surface expression of
CD103 on activated T cells is regulated by TGFβ (Smith et al.,
1994) as is the transcription of the αE gene (Robinson et al., 2001).
In vivo, TGFβ signaling is required for efficient induction of
CD103 expression by graft-infiltrating CD8 effector T cells (El-
Asady et al., 2005;Wang et al., 2004). Finally, both TGFβ and the
transcription factor Runx3 are required for CD103 expression on
the CD4 T cell line RLM-11-1 (Grueter et al., 2005) and either
knockdown or knockout (KO) of Runx3 markedly reduced the
frequency of CD103 expressingCD8+ Tcells (Grueter et al., 2005;
Yarmus et al., 2006). Hence, Runx3 positively regulates the
expression of CD103 during T cell development.
Mammalian Runx3 is one of three proteins comprising the
RUNT domain family of transcription factors RUNX (Cameron
and Neil, 2004; de Bruijn and Speck, 2004; Levanon and Groner,
2004; van Wijnen et al., 2004). In the thymus where the three
members Runx1, Runx2 and Runx3 are highly expressed
(Bangsow et al., 2001; Taniuchi et al., 2002; Vaillant et al.,
2002), the expression of Runx1 and Runx3 is confined to the
cortex and medulla, respectively (Woolf et al., 2003). Studies in
KO mice have delineated several cell-autonomous functions of
Runx3. Loss of Runx3 is associated with defects in neurogenesis,
thymopoiesis and dendritic cell (DC) function and with
development of colitis, gastritis and asthma like features (Levanon
et al., 2002; Fainaru et al., 2004;Woolf et al., 2003; Brenner et al.,
2004; Fainaru et al., 2005; Inoue et al., 2002; Levanon et al., 2003;
Taniuchi et al., 2002). In neurogenesis and thymopoiesis, Runx3
was required for development and survival of dorsal root ganglia
TrkC neurons (Levanon et al., 2002; Inoue et al., 2002) and for
silencing the CD4 gene during T cell development (Ehlers et al.,
2003; Woolf et al., 2003; Taniuchi et al., 2002). In the DC
compartment, Runx3 functions as a component of the TGFβ
signaling pathway (Fainaru et al., 2004; Fainaru et al., 2005) and
in its absence TGFβ-dependent development of skin Langerhans
(LC) cells was abrogated, as was TGFβ-dependent inhibition of
DC maturation (Fainaru et al., 2004; Fainaru et al., 2005).
Given the important functions of Runx3 in development of
epidermal LC (Fainaru et al., 2004; Fainaru et al., 2005) and
specifications of CD8-lineage T cells (Ehlers et al., 2003; Woolf
et al., 2003; Taniuchi et al., 2002), we have investigated the
function of Runx3 in biogenesis of Vγ3 DETCs. We show that
Runx3 is required for the proper development of embryonal
Vγ3 thymocytes and when lost their maturation and prolifer-ation in the thymus are impaired, resulting in a complete
absence of skin DETCs in adult KO mice. How does Runx3
regulate DETCs development? We found that in developing
Vγ3 DETCs Runx3 regulates the expression of both CD103
and IL-2Rβ that are markedly reduced on the KO Vγ3
thymocytes. While the diminished level of IL-2Rβ results in
impaired IL-2- and IL-15-dependent proliferation of the KO
Vγ3 thymocytes, the reduced level of CD103 may affect cell
migration and epithelial retention, leading to lack of skin
DETCs in the KO mice. As Runx3 is essential for the proper
development of LCs (Fainaru et al., 2004) and DETCs (this
report), the two main components of skin immunity (Borkowski
et al., 1996; Romani et al., 2003; Sharp et al., 2005b), it was
interesting to note that although cutaneous abnormalities have
been described in mice deficient in either LCs or DETCs
(Girardi and Hayday, 2005; Kaplan et al., 2005; Schon et al.,
2000; Sharp et al., 2005a), Runx3 KO mice neither developed
spontaneous skin lesions, under SPF conditions, nor did they
exhibit enhanced contact hypersensitivity (CHS). Using
transgenic mice bearing diphtheria toxin receptor in the
Langerin gene, two groups ablated skin LCs and demonstrated
that these cells are not essential for CHS (Bennett et al., 2005;
Kissenpfennig et al., 2005b; Kissenpfennig and Malissen,
2006). Thus, the cutaneous phenotype of Runx3 KO mice
supports the notion that dermal DCs are sufficient for induction
of T cell response to epicutaneous application of haptens.
Materials and methods
Mice and histology
Runx3 KO mice were generated as described previously (Levanon et al.,
2002) and bred on several genetic backgrounds including ICR, MF1, C57BL/6
and FVB. When crossed onto a C57BL/6 or FVB background, homozygotes
Runx3 KO did not survive postnatally (Levanon et al., 2002). Therefore, WT
mice and KO littermates of ICR and MF1 backgrounds were used for all the
experiments. Mice were bred and maintained in a pathogen-free facility. The
Institutional Animal Care and Use Committee (IACUC) of The Weizmann
Institute approved all mouse experiments. Analysis of KO mice (n=5) and WT
littermates (n=4) including males and females was conducted as previously
described (Levanon et al., 2002). Samples of dorsal interscapular skin and right
fore- or hindlimb paws were collected fixed in 10% neutral-buffered formalin
and embedded in paraffin. Section were cut at 4 μm and stained with
hematoxylin and eosin (Levanon et al., 2002).
Flow cytometry and cell sorting
Suspension of fetal thymocytes was obtained by teasing the thymic lobes
with fine forceps and passing through a nylon mesh. Suspension of epidermal
cells was prepared from ear skin of adult mice by treatment with trypsin as
described (Borkowski et al., 1996). Cells (1–10×105) were resuspended in PBS
supplemented with 2% fetal calf serum, 0.05% NaN3 and 5 to 25 mM EDTA.
After pre-incubation with anti-FcγII/III receptor mAb (2.4G2) to avoid non-
specific binding of mAb, saturating amounts of mAbs were added. Cells were
incubated for 30 min at 4 °C, washed, resuspended in FACS buffer and
analyzed. When necessary, cells were incubated with secondary reagents for
30 min on ice. In most cases TO-PRO3-iodide (Molecular Probes, Eugene, OR,
USA) was added prior to analysis to specifically label the non-viable cells. Flow
cytometry was performed by using a FACSCalibur (Becton Dickinson)
equipped with CELLQUEST software (Becton Dickinson). Preparative cell
sorting of CD8β+ splenocytes was performed using FACS Vantage cell sorter
(BD Biosciences). Monoclonal Abs used for staining and for in vitro T cell
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CD103-biotin (M290), TCRγδ (GL3), CD16/32 (2.4G2), CD3-purified and
CD3-biotin (145-2C11) (all from BD; Pharmingen). CD3-APC (145-2C11) and
IL-2Rβ (TM-β1) were from eBiosciences.
Immunofluorescence staining of epidermal sheets
Epidermal sheets were prepared from either embryo skin or adult ear by
incubation in 0.5 M ammonium thiocyanate for 20 min at 37 °C (Juhlin and
Shelley, 1977). Acetone-fixed epidermal sheets were then incubated with biotin-
conjugated CD3 mAb for 1 h at 37 °C, rinsed in PBS, mounted in buffered
glycerol containing 0.3 M 1,4-diazabicyclo [2.2.2] octane (Sigma Chemical,
USA) and examined by an Olympus IX71 fluorescent microscope.
Stimulation of T cells
For monitoring up-regulation of CD103 in T cells, cells were released from
spleen and erythrocytes removed by treatment with ACK buffer (0.15 M NH4Cl;
1 mM KHCO3; 0.1 mM Na2 EDTA). Splenocytes were depleted of adherent
cells, passed through a nylon mesh and 2×106 cells/ml were stimulated with
5 μg/ml plate bound anti-CD3 mAb and 2 ng/ml recombinant murine IL-2
(PeproTech Rehovot Israel) in the absence or presence of 5 ng/ml recombinant
human TGF-β1 or TGF-β2 (PeproTech Israel). Cell were cultured for 4 days in
RPMI 1640 supplemented with 10% heat-inactivated FCS (Gibco, USA), 100 U/
ml penicillin-streptomycin, 2 mM L-glutamine and 50 μM2-ME, in a humidified
5% CO2 at 37 °C. For FACS analysis, cells were stained with CD4, CD8β and
CD103mAbs. For monitoring Runx3 protein level in naïve vs. stimulated CD4 T
cells, splenocytes were stimulated with 2 μg/ml Con-A (Sigma, USA) in the
presence of IL-2 and TGF-β1 for 3 days after which CD4+ and CD4+CD103+
cells were sorted using the FACS Vantage and Runx3 protein was determined as
previously described (Woolf et al., 2003; Fainaru et al., 2004). IL-2 stimulation of
fetal thymocytes was performed as described (Leclercq et al., 1990b).
Measurement of apoptosis
Apoptosis was analyzed by quantifying exposed phosphatidylserine residues
on external cell membrane (Vermes et al., 1995). Cells were stained with Vγ3-
PE mAb, washed and stained with Aposcreen Annexin-V FITC (Southern
Biotech, USA) according to the manufacture's instructions. Prior to analysis by
flow cytometry, cells were counterstained with 2 μM TO-PRO3-iodide
(Molecular Probes, Eugene, OR, USA).
RT-PCR
RNA was isolated using EZ-RNA total RNA isolation kit (Biological
industries, Israel). cDNA was generated using Superscript II RNaseH− reverse
transcriptase (Invitrogen) and PCR products were derived using the sets of
oligonucleotides and PCR conditions indicated below: αE (sense) 5′-
CCAGAAGGCCAAAAATTTCA-3′ (anti-sense) 5′-TCAGCAGC-
GACTCCTTTTCCGCTT-3′; 60 °C; 30,25 cycles, yielding a 197-bp product.
β-Actin (sense) 5′-GATGACGATATCGCTGCGCTG-3′ (anti-sense) 5′-GTAC-
GACCAGAGGCATACAGG-3′; 55 °C; 19,17 cycles, yielding a 430-bp
product. Vγ3-Jγ1 RT-PCR was performed as described (Minagawa et al.,
2001). The primers used to detect Runx3 transcripts encoding the p33 and p46
proteins are as follows: for the p33 transcript, forward AGTCCTTGCCACTGT-
CAGC, reverse GTGAGGCTCTGCAGCGTAG. Size of PCR product 570 bp.
For the p46 transcript, forward GGCAAGATGGGCGAGAACAC, reverse
CGTAGGGAAGGAGCGGTCA. Size of PCR product 670 bp.Results
Runx3 KO mice lack skin DETCs
Skin immunity depends to a large extent on resident
Langerhans cells (LCs) and Vγ3 TCR-expressing DETCs.The requirment for Runx3 in the development of skin LC was
demonstrated (Fainaru et al., 2004), but its role in the biogenesis
of DETCs was not investigated. We examined epidermal sheets
of embryos and adult WT and KO mice by in situ fluorescent
staining with anti-CD3 antibodies (Ab). Skin of WT E18
embryos and 8-week old adult mice contained round and
dendritic shaped DETCs, respectively (Fig. 1A). In contrast, no
DETCs were detected in either embryo or adult Runx3 KOmice
(Fig. 1A). Further analysis of epidermal cells by flow cytometry
using anti CD3, CD103 and Vγ3 Abs verified the complete
absence of DETCs in Runx3 KO epidermis (Fig. 1B).
Epidermal sheets of adult WT and KO mice were also
immunostained with Langerin (CD207); a C type lectin
specifically expressed by LCs (Valladeau et al., 2002). No
staining was detected in KO epidermis, whereas abundant LCs
were stained in WT (Fig. 1C), confirming the previous
observation (Fainaru et al., 2004) that skin epidermis of
Runx3 KO mice completely lack LCs.
DETCs uniformly express non-diverse γδ TCR, composed
of Vγ3-Jγ1 and Vδ1-Dδ2-Jδ2 chains (Asarnow et al., 1988,
1989), with invariant junctional sequences identical to TCR of
early fetal thymocytes (Lafaille et al., 1989). Vγ3-Jγ1
transcripts were recently also detected in the gut of E18
mouse embryo (Minagawa et al., 2001). Using this information,
we next evaluated the presence of DETCs in skin and gut of WT
and KO mice using RT-PCR. Vγ3-Jγ1 transcripts were not
detected in either epidermis or gut of Runx3 KO E18 embryos
(Fig. 1D), reconfirming the complete absence of peripheral,
non-thymic, Vγ3 T cells in the KO mice.
Since a reduction in the number of DETCs is associated with
inflammatory skin lesions (Schon et al., 2000, 2002; Girardi et
al., 2002), we examined histologically skin samples from adult
KO and WT mice bred on two different genetic backgrounds
(Brenner et al., 2004; Levanon et al., 2002), MF1 and ICR.
Macroscopic and microscopic evaluation revealed no signs of
an inflammatory process in any of the mice examined (Fig. 1E).
Additionally, skin IHC analysis using TdT-mediated dUTP nick
end labeling (TUNEL) showed no increase in apoptosis in KO
epidermis (not shown). Nevertheless, there was a striking
difference in skin thickness primarily due to absence of
subcutaneous fat in the KO mice (Fig. 1E). This occurrence is
related to the markedly reduced body weight of the KO mice
(Brenner et al., 2004; Levanon et al., 2002). The epidermis was
of similar thickness in both WT and KO mice (Fig. 1E).
We next used IHC and Western blotting analysis of
epidermal differentiation markers to further examine the
epidermis of Runx3 KO mice. Comparison revealed that
distribution and morphological pattern of the spinous layer
marker K10 and the granular layer marker Loricrin were similar
in WT and KO mice (Fig. 1F). These results completely
conform to the recently reported data that show no major change
between Runx3 KO and WT in the overall morphology of the
skin and its appendages (Raveh et al., 2005). Skin sections of
Runx3 KO and WTwere also stained with anti-Runx3 Ab (Fig.
1G). Runx3 expression was detected in WT dermis in the hair
dermal papillae and in isolated cells in the epidermis. These
scattered Runx3-positive cells, which did not express
Fig. 1. Analysis of Runx3 KO skin shows complete absence of DETCs and LCs, but no structural or morphological changes, as compared to WT. (A) Lack of
epidermal DETCs in E18 embryos (top) and adult Runx3 KOmice (bottom). Epidermal sheets of E18 dorsal skin or 8 weeks old ear lobes fromWTand KOmice were
subjected to immunofluorescence using CD3-biotin Ab/Cy3-streptavidin. Fetal DETCs have a round shape and acquire the characteristic dendritic morphology in
adult. (B) Flow cytometry analysis of epidermal cell suspension reveals the absence of Vγ3+CD3+CD103+ DETCs in Runx3 KOmice. Epidermal cell suspension of 8-
week-old mice were stained with anti HSA, Vγ3 and CD103 Abs. Dot plot analysis depicts the distribution of CD103 vs. Vγ3 in gated HSAlow-positive cells. (C) Lack
of epidermal LCs in adult Runx3 KO mice. Epidermal sheets of 8 weeks old ear lobes from WT and KO mice were subjected to immunofluorescence using rat anti
Langerin Ab (1:200, secondary Ab: anti rat Cy3) (Kissenpfennig et al., 2005a). (D) Absence of Vγ3 RNA in epidermis of Runx3 KO mice. RNA obtained from WT
and KO epidermis (left panel) or from gut of E18 WTand KO embryos (right panel) was analyzed for presence of the Vγ3-Jγ1 transcript by RT-PCR. (E) Histological
analysis of skin from WT and KO mice revealed no inflammatory lesions. Sections of dorsal interscapular skin of WT (left panel) and KO (right panel) stained with
hematoxylin and eosin. Ep—epidermis, De—dermis, Sub Fat—subcutaneous fat (magnifications: ×10 and ×25). (F) IHC analysis of epidermal differentiation
markers (left panel) and Western blotting (right panel). Shown are the spinous layer marker K10 and the granular layer marker Loricrin. (G) Two days old back skin
sections from WT and Runx3 KO mice were analyzed using Runx3 Ab (Levanon et al., 2001). No Runx3-specific staining is observed in the KO section.
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DETCs. Consistent with this interpretation are the observations
that these cells first appear at birth, after which their density
increases (Raveh et al., 2005) and are MHCII and CD3 positive,
respectfully. No Runx3-specific staining was observed in
sections of Runx3 KO skin (Fig. 1G).Runx3 is required for the development of embryonal Vγ3
thymocytes
The complete absence of peripheral Vγ3 DETCs in Runx3
KO mice raised the possibility that Runx3 plays a critical role in
the development of Vγ3 thymocytes during fetal development;
707E. Woolf et al. / Developmental Biology 303 (2007) 703–714hence, we examined whether Runx3 is expressed in Vγ3
thymocytes. Immunostaining of WT, FACS sorted, E17.5 Vγ3
thymocytes revealed the expression of Runx3 in a large
proportion of Vγ3 thymocytes (Fig. 2A).
Immature TCR Vγ3 thymocytes, with a Vγ3low/HSAhigh
phenotype, differentiate into mature Vγ3high/HSAlow cells
during the last few days before birth (Leclercq et al., 1993).
To examine the development of fetal Vγ3 thymocytes in WT
and KO mice, E16.5 and E18.5 thymocytes were stained with
HSA and Vγ3 Abs and analyzed by FACS. Compared to WT, a
marked reduction in the proportion of Vγ3high cells was
observed among E16.5 KO thymocytes, with a concomitant rise
in the proportion of Vγ3med and Vγ3low cells (Fig. 2B). Of note,
the Vγ3med/Vγ3high ratio was 7-fold higher in the KO
compared to WT (0.6 in WT Vs 4.2 in KO), and almost all
Vγ3high cells in the KO displayed an HSAmed/high phenotype
(Fig. 2B) indicating a defect in the maturation process of KO
Vγ3 thymocytes. Supporting this conclusion is the observation
that even at a more advanced developmental stage (E18.5), the
proportion of Vγ3high cells in the KO remained low and theFig. 2. Impaired development of Vγ3 thymocytes in Runx3 KO mice. (A)
Runx3 is expressed in Vγ3 fetal thymocytes. E17 thymocytes were stained with
HSA-biotin and Vγ3-PE, followed by streptavidin-APC and Vγ3+ cells were
sorted by FACS. Isolated HSAlowVγ3+ thymocytes were placed on cover slip
and stained with a rabbit anti-Runx3 polyclonal Ab followed with donkey anti-
Rabbit Cy2 (green). Substantial fraction of cells displayed coexpression of
cytoplasmic/membranal Vγ3-PE (stained red) and nuclear Runx3-CY2 (stained
green). (B) Maturation of Runx3 KO Vγ3 thymocytes is impaired. Freshly
prepared cell suspensions of E16.5 (upper panel) and E18.5 (lower panel)
thymocytes, were double stained with HSA-FITC and Vγ3-PE and analyzed by
FACS. Vγ3med and Vγ3high subsets are gated and percentages of each
population are shown. Results are representative of three to four independent
experiments.average cell-HSA level was higher than in WT (Fig. 2B). These
results indicate that Runx3 is required for the proper
development of embryonal Vγ3 thymocytes and when Runx3
is lost their maturation in the thymus is impaired.
Runx3 regulates CD103 expression in Vγ3 thymocytes
The αEβ7 integrin CD103 is expressed on a substantial
portion of Vγ3 thymocytes and on the majority of skin resident
Vγ3 cells (Lefrancois et al., 1994). Whereas CD103-deficient
mice exhibit a marked reduction in skin DETCs (Schon et al.,
2002), not much is known about the role of CD103 in
development of thymic Vγ3+ DETC precursors during fetal
thymopoiesis. Because CD103 expression in CD8 T cells is
regulated by Runx3 (Grueter et al., 2005; Yarmus et al., 2006),
we compared the expression of CD103 on developing Vγ3 fetal
thymocytes of WT and Runx3 KO mice. E16.5 Vγ3med KO
thymocytes exhibited reduced CD103 expression, reflected in a
lower mean-fluorescence-intensity (MFI) (Fig. 3A). This lower
CD103 expression was more pronounced in Vγ3high thymo-
cytes, where both the MFI and the proportion of CD103
expressing cells were significantly reduced in the KO (Fig. 3A).
At E18.5, both Vγ3med and Vγ3high KO thymocytes exhibited
reduced expression of CD103 as compared to WT (Fig. 3B).
These data indicate that Runx3 is required for CD103
expression in developing Vγ3 thymocytes.
Since Runx3 functions as a component of the TGFβ
signaling pathway (Shi and Stavnezer, 1998; Fainaru et al.,
2004, 2005), and TGFβ can induce CD103 expression on T
lymphocytes (Kilshaw and Murant, 1991; Parker et al., 1992;
Robinson et al., 2001; Smith et al., 1994), we evaluated the
ability of TGFβ1 and TGFβ2 to induce expression of CD103 in
cultured fetal thymocytes. Analysis of incubated E16.5 WT
thymocytes showed that both TGFβ1 and TGFβ2 induced
CD103 expression on Vγ3+ fetal thymocytes (Fig. 4A). We
next asked whether Runx3 transcriptionally regulates CD103
expression in response to TGFβ using cultured primary CD4+ T
cells from WT and Runx3 KO mice. We employed CD4+
splenocytes because contrary to CD8 T cells, only a small
fraction (<6%) of TCRαβ CD4+ T cells normally express
CD103. WT and Runx3 KO splenocytes were cultured in the
presence or absence of TGFβ1. After 4 days in culture with
TGFβ, more than 40% of WT CD4+ T cells expressed CD103
whereas no such expression was observed on KO cells (Fig.
4B). As Runx3 expression in naïve CD4+ splenocytes is low
(Taniuchi et al., 2002; Woolf et al., 2003), we examined whether
T cell activation induces Runx3 expression in CD4+ spleno-
cytes. Western blot analysis clearly demonstrated that in vitro
stimulation of CD4+ splenocytes resulted in up-regulation of
Runx3 expression in both CD4+CD103+ and CD4+CD103−
splenocytes (Fig. 4C). Interestingly, this enhanced Runx3
expression was mainly due to transcriptional activation of the
gene P1 promoter (Bangsow et al., 2001), reflected by the
substantial amount of a truncated transcript, encoding the
Runx3 p33 protein, which was detected in activated KO CD4+
splenocytes (Fig. 4C) (Fainaru et al., 2004). The impact of
Runx3 on TGFβ2-mediated expression of CD103 was also
Fig. 3. Diminished CD103 expression in Runx3 KO Vγ3 fetal thymocytes. Cell suspensions of WT and KO E16.5 and E18.5 thymocytes were triple stained with
HSA-FITC, Vγ3-PE and CD103-biotin Abs, followed by reaction with streptavidin PE-Cy5 and analyzed by FACS. Results are representative of three to four
independent experiments. (A) CD103 expression in E16.5 gated Vγ3med (upper) and Vγ3high (lower) thymocytes is depicted. Percentages of CD103 expressing cells
are shown. Mean fluorescence intensities (MFI) of CD103 are indicated at the right corners of histograms. (B) CD103 expression in E18.5 Vγ3 thymocytes was
analyzed as in A.
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expression of CD103 was up-regulated in WT but not in KO
CD8+ splenocytes (Fig. 4D). When taken together these data are
consistent with the conclusion that Runx3 mediates the well-
documented TGFβ-induced expression of CD103 in cultured T
cells and that both TGFβ1 and TGFβ2 promote this induction.
Finally, we asked whether Runx3 directly regulates CD103
transcription. As mentioned earlier, CD103 is a heterodimer
composed of the αE and β7 chains each encoded by a separate
gene. As the β7 chain is highly expressed in T cells, the limiting
factor in CD103 expression is the transcription of the aE gene
(Robinson et al., 2001). We used RT-PCR to monitor aE
transcription in sorted CD8αβ+ T cells of WT and Runx3 KO
mice. In comparison to WT, transcription of αE in KO CD8+ T
cells was greatly diminished (Fig. 4E), attesting to the function of
Runx3 as a transcription regulator of CD103 in T cells. As
CD103-deficient mice exhibit a marked reduction in skin DETCs
(Schon et al., 2002), it is conceivable that the decreased CD103
expression in Runx3 KO T cells contributed to the complete
absence of peripheral, non-thymic, Vγ3 T cells in the KO mice.
Diminished expression of IL-2Rβ on Runx3 KO Vγ3
thymocytes is associated with a lower IL-2/IL-15-mediated
cell-proliferation and a higher apoptosis
Several studies have suggested a role for IL-2 and IL-15
signaling, through the IL-2Rβ chain, in Vγ3 Tcell developmentand DETCs localization in the skin. First, both IL-2 and IL-15
play a role in the development of Vγ3 T cells (De Creus et al.,
2002; Leclercq et al., 1990b). Second, mature fetal Vγ3
thymocytes and Vγ3 DETCs express the IL-2Rβ chain and in
utero treatment with anti-IL-2Rβ Ab abrogates DETCs
appearance in the adult skin (Kawai et al., 1998; Tanaka et
al., 1992). Third, both IL-2 and IL-15 interact with receptor
complexes that contain the γc, IL-2Rβ chain and a specific IL-
2R or IL-15Rα chain (de Jong et al., 1996; Giri et al., 1994).
Fourth, IL-2Rβ-deficient mice exhibit a moderate reduction of
mature Vγ3 cells in fetal thymus and a complete lack of skin
DETCs in adult mice (Kawai et al., 1998). Consequently, we
examined whether the expression level of IL-2Rβ on
developing Runx3 KO fetal thymocytes was altered.
FACS analysis of E18.5 Vγ3 thymocytes revealed a
substantially lower IL-2Rβ level on KO compared to WT
cells (Fig. 5A). This lower IL-2Rβ expression posed the
question as to whether it affects the response of KO Vγ3
thymocytes to IL-2. Leclercq et al. (1990b) have shown that
E17 to E19 Vγ3 thymocytes preferentially expand during in
vitro stimulation by IL-2. We therefore cultured E18.5 WT and
Runx3 KO thymocytes in the presence of IL-2 and monitored
the increase in the HSAlow Vγ3+ cell population between 24
and 72 h of incubation (Fig. 5B). We observed a 4 times higher
increase in WT HSAlow Vγ3+ thymocytes compared to KO
thymocytes (Fig. 5B) (28±3-fold increased of WT, compared to
7.2±0.75-fold of KO). The results indicate that Runx3 impacts
Fig. 4. Runx3 mediates TGFβ-dependent expression of CD103 in cultured primary T cells. (A) TGFβ up-regulates CD103 expression in E16 Vγ3+ thymocytes. WT
E16 thymocytes were cultured for 5 days with anti-TCRγδ Ab in the presence of IL-2 and IL-7 without or with TGFβ1 or TGFβ2. Cell suspensions were processed
and analyzed by FACS as detailed in Fig. 3B. CD103 expression in gated Vγ3+ thymocytes is shown. Results are representative of three to four independent
experiments. (B) Runx3 is required for TGFβ-dependent expression of CD103 in primary CD4+ T cells. Splenocytes from WT and Runx3 KO mice were depleted of
adherent cells and stimulated with plate bound anti-CD3 and IL-2 in the presence or absence of TGFβ1 (5 ng/ml). After 4 days, cells were harvested and stained with
CD4, CD8β and CD103 Abs and analyzed by FACS. To-Pro3 was added immediately before analysis and dead cells were gated out. CD4+ cells were gated and
monitored for CD103 expression. Results are representative of five independent experiments. ((−) TGFb—solid line; (+) TGFb—interrupted line). (C) Expression of
Runx3 in activated CD4+ and CD4+CD103+ T cells. Left panel: WT splenocytes were cultured and stimulated with ConA, IL-2 and TGFβ1. After 3 days, cells were
FACS sorted into CD4+ and CD4+CD103+ T cell subsets proteins extracted and analyzed by Western blots using polyclonal Rabbit anti-Runx3 and anti-GAPDH Abs.
A marked stimulation of the two Runx3 protein bands of 48 and 46 kDa was evident in activated CD4+ and CD4+CD103+ splenocytes compared to non-activated naïve
cells. Right panel: activated WT and KO CD4+ splenocytes were FACS sorted; RNAwas derived and analyzed by RT-PCR. The WT and KO RT-PCR products are
designated Runx3 p46 and p33, respectively. (D) Runx3 regulates TGFβ2-mediated expression of CD103 in CD8+ T cells. WT and Runx3 KO splenocytes were
cultured for 5 days in the presence of anti-CD3 Ab and IL-2 and in the presence or absence of TGF-β2 (5 ng/ml). Cells were stained with CD4, CD8β and CD103 Abs
and CD103 expression was determined in gated CD8β+ cells. Results are representative of three independent experiments. (E) Runx3 transcriptionally regulates the
expression of the αE gene. FACS-sorted CD8β+ splenocytes were obtained and extracted RNA used in an RTPCR reaction to detect αE mRNA. (197 bp; 32 and 29
cycles). The corresponding semi-quantitative β-actin RT-PCR is shown (490 bp; 20 and 16 cycles).
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level on KO Vγ3 thymocytes diminished resulting in a lower
proliferation in response to IL-2. This conclusion was supported
by the finding that the proliferation rate of KO Vγ3 thymocytes
in response to IL-15 was similarly lower compared to WT (WT
15±2.7; KO 2±0.8; Fig. 5C).
IL-2 not only stimulates in vitro proliferation of Vγ3
thymocytes, but it can also rescue mature Vγ3 thymocytes from
apoptosis (Leclercq et al., 1995). We asked whether cultured
Runx3 KO Vγ3 thymocytes, that express lower levels of IL-
2Rβ, display increased apoptosis during IL-2 stimulation as
compared to WT thymocytes (Figs. 5D and E). At 24 h after
seeding, KO cultures contained twice as many apoptotic Vγ3
cells compared to WT (KO—53±4.6%; WT—25±5.7%) (Fig.
5D), and this preponderance of apoptotic Vγ3 cells among theKO thymocytes increased at 36 h in culture (KO—50±2.1%;
WT—14±2.1%) (Fig. 5E). Together these data show that in
Runx3 KO Vγ3 thymocytes, the impaired expression of IL-
2Rβ is associated with diminished effects of IL-2 and IL-15 on
cell proliferation and apoptosis.
Discussion
During T cell development, Runx3 is highly expressed in
double positive CD4+/CD8+ thymocytes and in mature CD8+ T
cells (Taniuchi et al., 2002; Woolf et al., 2003), acting as both
positive and negative regulator of target genes (Yarmus et al.,
2006). In CD4+/CD8+ thymocytes, Runx3 negatively regulates
CD4 expression whereas in mature CD8+ T cells it positively
regulates cell growth-promoting genes. Accordingly, in Runx3-
Fig. 5. Decreased IL-2Rβ expression on Runx3 KO Vγ3 thymocytes results in diminished cell response to IL-2/IL-15. (A) Reduced IL-2Rβ expression on Runx3 KO
Vγ3+ fetal thymocytes. E18.5 thymocytes were isolated from WT and KO embryos and triple stained with HSA-FITC, Vγ3-PE and CD122-biotin (IL-2Rβ) Abs,
followed by reaction with streptavidin-PE-Cy5 and analyzed by FACS. IL-2Rβ expression in Vγ3+ cells is shown together with the mean fluorescence intensity of
CD122 in WT and KO cells. Results are representative of three independent experiments. (B and C) Diminished response of Runx3 KO Vγ3 thymocytes to IL-2 and
IL-15 stimulation. Thymocytes were obtained from E18.5 embryos and cultured in the presence of 500 U/ml rIL-2 (B) and 200 ng/ml IL-15 (C). Duplicate cultures
were harvested at 24 and 72 h post-plating, stained for expression of HSA-FITC and Vγ3-PE and analyzed by FACS. Fold increase in the proportion Vγ3 cells in four
independent experiments and are presented as mean±SD in the histogram. (D and E) Diminished response of Runx3 KO Vγ3 thymocytes to IL-2 antiapoptotic effect.
E18.5 Vγ3+ fetal thymocytes were obtained and cultured as in B above. At 24 (D) and 36 h (E) after seeding, cells were harvested and stained with Vγ3-PE and
Annexin-V-FITC. To-Pro3 was added immediately prior to FACS analysis. Histograms depict percentage of Vγ3/Annexin/To-Pro3 triple positive cells (mean±SD) in
three independent experiments.
710 E. Woolf et al. / Developmental Biology 303 (2007) 703–714
711E. Woolf et al. / Developmental Biology 303 (2007) 703–714deficient mice CD4 silencing is abrogated and CD8+ T cell
proliferation is diminished (Ehlers et al., 2003; Taniuchi et al.,
2002; Woolf et al., 2003; Yarmus et al., 2006). Here we show
that Runx3 is expressed in Vγ3+ thymocytes and when absent
the skin population of Vγ3 DETCs largely diminished,
underscoring the importance of Runx3 function for proper
development of Vγ3+ DETCs. Interestingly, Runx3 is also
essential for development of LCs, as Runx3 KO mice lack skin-
resident LCs (Fainaru et al., 2004). We have recently reported
the existence of a CD3+ cell population in epidermal sheets of
Runx3 KO mice (Fainaru et al., 2004). However, further
analysis that culminated in the present study revealed that the
observed staining with anti CD3 antibodies was actually a non-
specific absorption, which was mistakenly interpreted as DETC.
As further demonstrated in Fig. 1G, this correction does not
affect the conclusion of the Fainaru et al. (2004) study that the
epidermis of Runx3 KO mice is devoid of LCs. Hence, Runx3-
deficient mice constitute a unique mouse model in which both
LCs and DETCs are missing.
Given the fact that Vγ3+ DETCs and LCs are important
components of skin immunity (Kabelitz et al., 2005; Romani et
al., 2003; Sharp et al., 2005b), it is worth noting that Runx3 KO
mice neither developed skin lesions nor did they display
increased epidermal apoptosis or contact hypersensitivity (Fig.
1 and unpublished observations). This finding is intriguing as
other mouse mutants that lack either DETCs or LCs exhibited
skin inflammation (Girardi et al., 2002; Schon et al., 2000),
increased epidermal apoptosis (Sharp et al., 2005a) or enhanced
contact hypersensitivity (CHS) (Kaplan et al., 2005), respec-
tively. On the other hand, the lack of enhanced CHS in our
Runx3 KO mice is consistent with recent reports demonstrating
that LCs are not essential for CHS (Bennett et al., 2005;
Kissenpfennig et al., 2005b; Kissenpfennig and Malissen,
2006). Thus, the cutaneous phenotype of Runx3 KO mice
supports the notion that CHS is mediated mainly by dermal DC
(Bennett et al., 2005; Kissenpfennig et al., 2005b; Kissenpfen-
nig and Malissen, 2006). However, more studies will be
required to define the physiological factors underlying the lack
of skin lesions in Runx3 KO mice because in addition to its
importance for DCs, LCs and DETCs development and
function, Runx3 also regulates T cells differentiation and
homeostasis (Fainaru et al., 2004; Taniuchi et al., 2002; Woolf
et al., 2003).
The complete absence of skin Vγ3+ DETCs in Runx3 KO
mice incited us to examine whether the absence of Runx3
impacted on early stages of Vγ3 thymocyte development. We
found that in KO fetuses, the maturation of Vγ3 thymocytes
was impaired resulting in a marked reduction in the proportion
of Vγ3high/HSAlow cells in the thymus. But what is the
underlying cause for this reduced proportion of Vγ3high/
HSAlow fetal thymocytes in the KO mice?
Integrins play a pivotal role in thymocyte development
(Schmeissner et al., 2001), by influencing stage-specific cell
growth and differentiation (Kutlesa et al., 2002). The integrin
CD103 mediates T cell adhesion to epithelial cells through
binding to its only known ligand E-cadherin, which is
selectively expressed on epithelial cells (Cepek et al., 1994).As CD103 is expressed on 40–60% of Vγ3+ thymocytes and on
the majority of skin-resident Vγ3+ cells, it was suggested that
CD103 plays a role in thymic development and subsequent
migration of Vγ3 cells (Lefrancois et al., 1994). Indeed,
CD103-deficient mice exhibit a marked reduction in epidermal
Vγ3 DETCs (Schon et al., 2002). We find, as was previously
reported for CD8+ T cells (Grueter et al., 2005; Yarmus et al.,
2006), that Runx3 mediates TGFβ-induced expression of
CD103 in Vγ3+ thymocytes and in activated CD4+ T cells.
Specifically, in developing Vγ3 thymocytes, Runx3 positively
regulates CD103 expression during the transition from
immature Vγ3med/HSAhigh to mature Vγ3high/HSAmed/low
thymocytes.
It was previously reported that expression of CD103 in
cultured peripheral T cells is induced by TGFβ (Kilshaw and
Murant, 1990; Parker et al., 1992; Robinson et al., 2001). We
found, as did Grueter et al. (2005), that this induction of
CD103 expression in cultured T cells was mediated by Runx3.
Of note, in naïve CD4+ T cells that express low level of
Runx3 (Fig. 4C and Taniuchi et al., 2002; Woolf et al., 2003),
expression of Runx3 is up-regulated upon cell activation,
concomitantly with TGFβ-dependent induction of CD103.
This finding suggests that during Vγ3 T cell maturation in
vivo, Runx3 mediates the expression of CD103 in response to
TGFβ signaling. It also raises the possibility that in fetal
thymus either TGFβ1 and/or TGFβ2 can induce CD103
expression, as both are produced in thymic epithelium (Lai et
al., 1997; Takahama et al., 1994). This notion is supported by
our finding that both TGFβ1 and TGFβ2 can induce CD103
expression in cultured fetal Vγ3 thymocytes and by the
observation that TGFβ1-deficient mice are not devoid of skin
DETCs (Borkowski et al., 1996), probably due to compen-
sation by TGFβ2. No such compensation could occur in the
KO mice because in the absence of Runx3, the KO Vγ3
thymocytes respond neither to TGFβ1 nor to TGFβ2. As a
result, expression of CD103 diminishes leading to impaired
maturation of Vγ3 precursors. CD103 could also be involved
in Vγ3 cell proliferation, as E-cadherin expressing thymic
epithelial cells are capable of inducing proliferation of
CD8+CD103+ but not of CD8+CD103− T cells (Kutlesa et
al., 2002). Thus, diminished CD103 expression in KO Vγ3
thymocytes could affect cell proliferation and thereby impacts
on DETCs development. Indeed, Runx3 KO CD8+ T cells, in
which CD103 expression was diminished (Grueter et al.,
2005; Yarmus et al., 2006), display a largely reduced
proliferation rate (Taniuchi et al., 2002; Woolf et al., 2003).
These data underscore the importance of CD103 for the
development of DETC precursors in fetal thymus. But does
the reduction in CD103 on Runx3 KO Vγ3 thymocytes fully
explain the complete absence of skin DETCs in the KO mice?
Fetal Vγ3 DETC precursors depend on IL-2/IL-15 signaling
through the IL-2Rβ for their development. When IL-2/IL-15
signaling is lost, as in IL-2Rβ or IL-15-deficient mice, a marked
reduction in mature Vγ3+ fetal thymocytes and skin DETCs
occurs (De Creus et al., 2002; Kawai et al., 1998). We show that
in Runx3 KO Vγ3 thymocytes the decreased expression of IL-
2Rβwas associated with a lower response of the KO cells to IL-
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the KO Vγ3 thymocytes to IL-2/IL-15 stimulation is, in part,
due to the lower CD103 expression on these cells. Moreover,
signaling through the IL-2Rβ and γ chains is also important for
maintaining the viability of mature Vγ3 thymocytes in culture
(De Creus et al., 2002; Leclercq et al., 1990a,b). Indeed, when
cultured in the presence of IL-2, the proportion of apoptotic
cells among KO Vγ3 thymocytes was significantly higher
compared to WT. Additionally, as thymic epithelial cells at E14
to E18 express E-cadherin (Lee et al., 1994), it is possible that
diminished CD103-E-cadherin interactions in the KO contrib-
ute to the apparent lower IL-2/IL-15 responsiveness. Finally, as
IL-2Rβ expression on Vγ3 fetal thymocytes correlates with
expression of the skin homing chemokine receptor CCR10 on
these cells (Xiong et al., 2004), it is possible that the skin-
homing capability of KO Vγ3 thymocytes was also compro-
mised, which may further contribute to the complete absence of
skin DETCs in Runx3 KO mice.
In summary, we demonstrated that Runx3 plays an essential
role in the development of DETC precursors in fetal thymus. In
the absence of Runx3, expression of CD103 and IL-2Rβ in fetal
Vγ3 thymocytes diminished, which compromised the signaling
through these surface receptors. As a result, the maturation and
proliferation of DETC precursors in the thymus decreased and
their apoptosis rate increased, leading to a complete lack of skin
DETCs in the KO mice.
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